Home/Filings/4/0001062993-24-001433
4//SEC Filing

Dickinson Klara 4

Accession 0001062993-24-001433

CIK 0001042074other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 6:30 PM ET

Size

7.1 KB

Accession

0001062993-24-001433

Insider Transaction Report

Form 4
Period: 2024-01-24
Dickinson Klara
SVP, Regulatory Affairs & QA
Transactions
  • Award

    Common Stock

    2024-01-24+21,00021,000 total
  • Award

    Employee Stock Option (right to buy)

    2024-01-24+78,00078,000 total
    Exercise: $22.85Exp: 2034-01-23Common Stock (78,000 underlying)
Footnotes (2)
  • [F1]The grant shall vest as to 1/4 of the shares on each of January 15, 2025, January 15, 2026, January 15, 2027 and January 15, 2028.
  • [F2]The option grant vests as to 1/48 of the underlying shares monthly from January 1, 2024.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001339895

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 6:30 PM ET
Size
7.1 KB